✉news HealthMedicine first seen 5 h ago, last 1 h ago, peak #19
Kodiak Sciences Says Eye Drug Matches Regeneron Rival
Original: Kodiak Sciences Says Eye Drug on Par with Regeneron's Medicine
Kodiak Sciences announced that its experimental eye drug performs on par with Regeneron's established eye medicine, positioning the biotech as a potential competitor in the treatment of retinal diseases. The claim, reported by Benzinga, puts a spotlight on Kodiak's clinical data and its ability to challenge Regeneron's dominance in the ophthalmology market, where its blockbuster therapy has long set the standard of care.
Why now: Investors and biotech watchers are reacting to Kodiak's claim that its drug could rival a dominant Regeneron therapy.
Rank over time, top of the chart is #1. 4 snapshots from 5 h ago to 1 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/243958